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Abstract
Intensive insulin therapy and protein restriction delay the development of nephropathy in a variety of conditions, but few
interventions are known to reverse nephropathy. Having recently observed that the ketone 3-beta-hydroxybutyric acid (3-
OHB) reduces molecular responses to glucose, we hypothesized that a ketogenic diet, which produces prolonged elevation
of 3-OHB, may reverse pathological processes caused by diabetes. To address this hypothesis, we assessed if prolonged
maintenance on a ketogenic diet would reverse nephropathy produced by diabetes. In mouse models for both Type 1
(Akita) and Type 2 (db/db) diabetes, diabetic nephropathy (as indicated by albuminuria) was allowed to develop, then half
the mice were switched to a ketogenic diet. After 8 weeks on the diet, mice were sacrificed to assess gene expression and
histology. Diabetic nephropathy, as indicated by albumin/creatinine ratios as well as expression of stress-induced genes,
was completely reversed by 2 months maintenance on a ketogenic diet. However, histological evidence of nephropathy was
only partly reversed. These studies demonstrate that diabetic nephropathy can be reversed by a relatively simple dietary
intervention. Whether reduced glucose metabolism mediates the protective effects of the ketogenic diet remains to be
determined.
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Introduction
While intensive insulin therapy and other interventions slow the
development of diabetic complications [1], there is far less
evidence that these interventions reverse diabetic complications.
For example, tight glucose control prevented the development of
nephropathy (as indicated by proteinuria) in a rat model of Type 1
diabetes, but did not reverse nephropathy once proteinuria had
developed [2]. Thus there is a general consensus that diabetes is
associated with progressive and cumulative processes that are
much more amenable to retardation than to reversal. Neverthe-
less, from a clinical perspective, reversing pathologies associated
with diabetes would be far more valuable than simply delaying
their onset.
We have proposed that both diabetic complications and age-
related pathologies develop due to a progressive and cumulative
effect of glucose metabolism that produces a bistable hysteretic
effect on gene expression [3]. In addition to glycolytic enzymes
that would be expected to produce oxidative stress [3], glucose
metabolism also induces a variety of molecular responses such as
thioredoxin-interaction protein [4] and p65 [5] that could
plausibly contribute to nephropathy. Indeed, the latter induc-
tion is persistent, even after normalization of glucose, thus
exemplifying glucose-induced hysteresis and its clinical corre-
late, metabolic memory, including in nephropathy [6]. Further-
more, based particularly on detailed analysis of the hysteretic
behavior of the lac operon [7,8], we have hypothesized that
sufficiently prolonged and robust reduction in glucose metab-
olism or molecular responses to glucose metabolism may reverse
this bistable molecular state, leading to reversal of pathology [3].
While examining basic mechanisms mediating molecular
responses to glucose, we observed that the ketone 3-beta-
hydroxybutyric acid (3-OHB) blocked the inhibition of agouti-
related peptide by glucose [9]. Together with evidence
suggesting that the ketogenic diet produces a prolonged
exposure to 3-OHB, these data suggest that the ketogenic diet
may prevent and even reverse pathologies associated with
diabetes. One manipulation that produces a chronic elevation in
3-OHB levels is caloric restriction, and we have hypothesized
that this elevation in 3-OHB may mediate many of the
protective effects of dietary restriction [3]. On the other hand,
chronic caloric restriction is not a plausible intervention for
clinical use. An alternative approach to producing chronic
elevation of 3-OHB is a ketogenic diet, used clinically to treat
refractory epilepsy [10]. Although the mechanism by which the
ketogenic diet reduces the frequency of epileptic seizures is not
entirely understood, most evidence suggests that it does so by
reducing neuronal glucose metabolism [11,12]. Furthermore,
analysis of the effect of the ketogenic diet on gene expression is
consistent with the hypothesis that the ketogenic diet does re-
route cellular metabolism away from glucose utilization and
toward the use of alternative fuels, presumably including 3-
OHB [13,14]. In the present studies we therefore examined if a
ketogenic diet would reverse pathologies produced by diabetes.
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18604We focused on nephropathy because kidney function is
relatively amenable to repetitive assessment simply by repetitive
collection of urine, thus allowing definitive determination that
pathology had developed before beginning the dietary inter-
vention. These studies clearly demonstrate that diet can reverse
diabetic kidney disease even after it has developed.
Methods
Ethics Statement
All studies were approved by the appropriate institutional
animal review board (Institutional Animal Care and Use
Committee, IACUC, Mount Sinai School of Medicine; Approval
ID 07-0044, ‘‘Reversal of Diabetic Complications by Diet’’). All
animals used in these studies were obtained from The Jackson
Laboratory (Bar Harbor, ME) and housed with free access to
food and water under 12:12-h light-dark cycle (lights on at 7:00
A.M.).
Akita diabetic nephropathy
Male 10-week old C57Bl/6J mice (wild-type or with the Akita
mutation (JAX#003548, C57BL6-Ins2akita/J) (n=28 for each
genotype) were purchased from Jackson Laboratories. At 20
weeks of age urine was collected for urinalysis, and development
of diabetic nephropathy was confirmed by elevated albumin-to-
creatinine ratio (ACR). At that time, half of wild-type mice and
half of the Akita mice were placed on a ketogenic diet (5%
carbohydrate, 8% protein, 87% fat) (#F3666, BioServ, French-
town, NJ). The remaining animals were maintained on a
standard AIN-93M-based high-carbohydrate control diet (64%
carbohydrate, 23% protein, 11% fat). Mice were maintained on
the ketogenic diets for 8 weeks at which time urine was collected
for determination of ACR, followed by sacrifice using a balanced
design at the start of the light period (10:00 A.M. to 2:00 P.M.).
Mice were sacrificed by decapitation after a brief exposure to
carbon dioxide. However, within 2 weeks after switching mice to
the ketogenic diet, 2 mice on the chow diet had died, whereas
none of the mice on the ketogenic diet had died, raising the
possibility that by 8 weeks there would be too few chow control
mice left to allow direct comparison of gene expression.
Therefore all mice on the chow control diet were sacrificed 2
weeks after switching the experimental mice to the ketogenic diet,
6 weeks before those mice were sacrificed. No mice on the
ketogenic diet died spontaneously during the course of the study.
Kidneys were collected and fresh-frozen for analysis of gene
expression.
db/db diabetic nephropathy
Male 10-wk old C57Bl/KsJ (wild-type or db/db; JAX#000642,
BKS.Cg-Dock7
m+/+Leprdb/J) (n=20 each genotype) were pur-
chased from Jackson Laboratories. At 12 weeks of age half of
each genotype were placed on a ketogenic diet (5% carbohydrate,
8% protein, 87% fat). The remaining animals were maintained
on a standard AIN-93M-based high-carbohydrate control diet
(64% carbohydrate, 23% protein, 11% fat). Urine was collected
after 8 weeks on the diet in all groups. Body weight, blood
glucose, and blood ketone levels were monitored throughout the
study. After 8 weeks on the diet, all animals were sacrificed
following a balanced design at the start of the light period (10:00
A.M. to 2:00 P.M.). Mice were killed by decapitation after a brief
exposure to carbon dioxide. Kidneys were collected and one was
fresh-frozen for gene expression analysis, and the other fixed for
renal histopathology.
Measurement of UAE
Excretion of urinary albumin was determined using albumin-to-
creatinine ratio (ACR) in 24 hr urine collections. Twenty-four-
hour urine was collected using NalgeneH Metabolic Cage System
(Rochester, NY). Nalgene metabolic cages are designed to allow
efficient separation of the urine and feces from a single mouse. The
concentration of creatinine in urine was determined using The
Creatinine Companion kit (Exocell, Philadelphia, PA) and that of
albumin using Albuwell M kit (Exocell).
Glomerular Morphometry
At time of sacrifice, kidneys were harvested for pathological
examination. One kidney was fresh-frozen for gene expression
analysis, and the other was fixed in 10% neutral buffered formalin
(Sigma-Aldrich Co., St. Louis, MO). The formalin-fixed tissue was
embedded in paraffin and 4-mm sections were stained with
periodic acid-Schiff stain (American Histolabs, Gaithersburg,
MD). Glomerular sclerosis was quantified using a semi-automatic
image analysis technique with examination of the total cortical
area. To perform the morphologic analysis, a total of 30 glomeruli
were randomly selected from each kidney moving the slide from
the outer to the inner cortex in a random fashion to obtain non-
overlapping sample fields. Glomerular images were recorded using
a CCD camera (Sony, Tokyo, Japan) mounted on light
microscope (Zeiss, Gottingen, Germany). Glomerular tuft surface
area was obtained using the MetaMorph image analysis computer
program (Universal Imaging Co., West Chester, PA). From the
glomerular tuft image, the amount of periodic acid– Schiff–
positive material was selected automatically by use of the color
recognition properties of the software. The number of pixels in this
area was considered to represent the area of sclerosis and was
expressed as a fraction of the tuft surface area.
In vitro assessment of cytoprotective effects of the
ketone 3-beta-hydroxybutyrate (3-OHB)
To directly assess if the ketone 3-OHB is cytoprotective, we
adapted a basic assay for cellular sensitivity to oxidative stress
[15,16,17,18,19,20], and further validated the protocol for the
modulation of oxidative stress by glucose. Primary cortical neurons
were prepared from embryonic (E16) brains using standard
methods [21,22]. Neurons were maintained at 20 mM glucose
in Neurobasal/B27 medium (Invitrogen) for 5 days to allow
neuronal expansion to the appropriate density. Cells were then
exposed to various concentrations of 3-OHB and/or glucose for
2.5 hours, then exposed to 100 uM hydrogen peroxide for one
hour (controls were simply exposed to a change in medium
without hydrogen peroxide). After one hour the medium was
removed, wells are washed three times with fresh medium (all wells
now at 20 mM glucose). Twenty-four hours later, cellular viability
was assessed using the CKK-8 assay (Dojindo Molecular
Technologies).
Extraction of kidney RNA and cDNA synthesis
To obtain RNA for gene expression analysis by quantitative PCR,
renaltissuewashomogenizedintubescontainingRLTbuffer(Qiagen)
supplemented with 2-ME, and total RNA was extracted using an
RNeasy Mini Kit (Qiagen). Total RNA was quantified using a
Biophotometer (Eppendorf). Due to capacity limitations of the PCR
array plates, four to five samples from each experimental group were
selected(basedonsuperiorRNAquality)andweresubjectedtoreverse
transcription. 1 ug of high-quality total RNA was used for cDNA
synthesis using RT
2 First Strand Kit (SAbiosciences). All procedures
were performed according to the manufacturers’ protocols.
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2 Profiler
TM PCR Arrays
RT
2 Profiler PCR Array (SuperArray Bioscience Corporation)
technology for gene expression analysisentailsasynthesisbetweenthe
profiling capabilities of DNA microarray and the quantitative
reliability and sensitivity of quantitative PCR. The results are highly
reproduciblewithinthesameassayrunorbetweendifferentassayruns.
Two cataloged RT
2ProfilerPCRArrayswereusedtosimultaneously
quantify mRNAs of 160 genes (PAMM-065 – Oxidative Stress and
Antioxidant Defense PCR Array, PAMM-003 – Stress & Toxicity
PCR array), including five ‘‘housekeeping genes’’ in 384-well plates
according to the protocol of the manufacturer (SuperArray Biosci-
ence). The qPCR reactions were carried out using an ABI Prism 7900
thermocycler.Averageexpressionofthefive‘‘housekeepinggenes’’on
the array were used to normalize the gene expression by the DDCt
method. Data were analyzed using a web-based software program
provided by the manufacturer with additional analysis using
GraphPad Prism 4 for Macintosh.
Additional RT-PCR
Quantitative PCR for three genes – nephrin, podocin and ZO-1
(Tjp1, tight junction protein 1) – was carried out on separate 384-
well plates using primers purchased from SABiosciences and
normalized to expression levels of Rpl13a (Ribosomal protein
L13a). The qPCR reactions were carried out using an ABI Prism
7900 thermocycler with conditions specified by SABiosciences for
their RT
2 qPCR Primer Assays.
Blood chemistry
Blood glucose was measured by a Bayer Contour glucose meter
(Bayer, Mountain View, CA). Blood 3-OHB was measure by a
Precision Xtra Ketone Monitoring System (Abbott Laboratories.
Abbott Park, IL).
Data Analysis
All data are presented as mean 6 SEM. Statistical analysis was
performed using GraphPad Prism 4.0 by one-way ANOVA
followed by Newman-Keul’s post hoc test. P,0.05 indicates
statistical significance.
Results
Reduction of blood glucose and increase in blood 3-OHB
by ketogenic diet
As expected, the ketogenic diet produced elevated blood 3-
OHB in all groups, particularly in the diabetic mice (Table 1).
Furthermore, after 2 months on the ketogenic diet blood glucose
was reduced in wild-type mice, completely normalized in Akita
(Type 1) and partly normalized in db/db (Type 2) diabetic mice.
The ketogenic diet also reduced body weight in wild-type mice but
not in diabetic mice, even though the diet reduced caloric intake in
Table 1. Physiological characteristics.
Body Weight (g) Blood Glucose (mg/dl) Blood 3-OHB (mmol/L)
Wt-Chow 33.760.75 134.6610.2 0.1560.02
Wt-Keto 29.660.67{ 97.365.3{ 0.6360.1{
Akita-Chow 21.261.25{ 441.9639{ 0.4760.1{
Akita-Keto 23.060.68{ 113.668.5 2.3460.3{
Wt-Chow 26.260.37 125.866.3 0.260.02
Wt-Keto 23.860.81{ 90.965.2{ 1.160.2{
db/db-Chow 39.661.88{ 60160.0{ 0.460.05{
db/db-Keto 54.561.53{ 299654.5{ 1.860.5{
{p,0.05 compared to respective Wt-Chow groups.
doi:10.1371/journal.pone.0018604.t001
Figure 1. Development of albuminuria in mouse models of
type 1 and type 2 diabetes and its reversal by the ketogenic
diet. ACR in diabetic Akita mice (A) and in diabetic db/db mice (B) with
respective age-matched control mice, fed either the ketogenic diet or
chow diet for 8 weeks. Urine was collected and ACR measured 8 weeks
after starting the diet regimens. Data are means 6 SE (n=10–14 for all
groups). *p,0.05 (ANOVA) vs. WT-Chow group (or vs. diabetic-Chow
groups as indicated by the horizontal brackets).
doi:10.1371/journal.pone.0018604.g001
Reversal of Diabetic Nephropathy by Ketogenic Diet
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18604db/db mice. None of the conditions influenced blood pH,
although there was a non-significant trend toward reduced blood
pH (i.e., acidification) in diabetic mice, and the ketogenic diet
reversed this trend.
Reversal of albuminuria in diabetic mice
As anticipated [23] Akita mice developed hyperglycemia
around 4 weeks of age and by 20 weeks of age Akita mice had
all developed nephropathy on the control diet, as indicated by a
Figure 2. Diabetic nephropathy is associated with a similar profile of gene expression for oxidative stress and toxicity related
transcripts in models of Type 1 (Akita) and Type 2 (db/db) diabetes – reversal with ketogenic diet. Real-time PCR gene expression was
assessed by RT
2 Profiler PCR Arrays from SABiosciences. The ketogenic diet reverses the kidney gene expression profile associated with diabetic
nephropathy in both the Akita and db/db mice. Data for each gene was normalized to a panel of housekeeping transcripts and expressed as fold
change compared to the WT-Chow group. Data are means 6 SE (n=4–5 for all groups). *p,0.05 (ANOVA) vs. WT-Chow group (or vs. diabetic-Chow
groups as indicated by the horizontal brackets).
doi:10.1371/journal.pone.0018604.g002
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(Figure 1A). At that point half of the diabetic Akita mice and half
of the euglycemic mice were placed on the ketogenic diet, whereas
half of the diabetic and half of the euglycemic mice were continued
on the control (normal high-carbohydrate) diet. Within one week
after switching to the ketogenic diet, blood glucose in Akita mice
was completely normalized (127+/217 mg/dl), without insulin
treatment; blood glucose fell slightly in the euglycemic mice (83+/
28 mg/dl) on the ketogenic diet. Within 2 weeks, 4 of the Akita
mice on the control diet had died, reducing the n to 8, whereas
none of the mice on the ketogenic diet had died. Since it was clear
that all the control Akita mice would be dead within 2 months
(consistent with other survival curves of mice with Type 1 diabetes
[24]), when we anticipated the Akita mice would be sacrificed,
thus preventing post-sacrifice comparison of kidney oxidative stress
and histology, we elected to sacrifice all mice on the control diet
(wild-type and Akita), and to continue to monitor blood glucose
and urinary albumin/creatinine ratios in mice on the ketogenic
diet. Remarkably, within 2 months, diabetic nephropathy was
completely reversed as indicated by urinary albumin/creatinine
ratios (Figure 1A). Figure 1A shows just the data from the group of
Akita mice that was placed on the ketogenic diet, for clarity.
‘‘Akita-Chow’’ actually refers to the group of Akita mice that were
on chow up until 20 weeks, then switched to the ketogenic diet.
‘‘Akita-Keto’’ refers to the same mice at 28 weeks, after having
been on the ketogenic diet for 8 weeks. The ketogenic diet had no
effect on albumin/creatinine ratios in euglycemic control mice.
The key observation is that after 8 weeks on the ketogenic diet, the
formerly ‘‘Akita/Chow’’ mice exhibited complete reversal of
diabetic nephropathy, as demonstrated by albumin/creatinine
ratios. Similarly, db/db mice developed hyperglycemia by 12
weeks of age, at which time half of the mice were switched to the
ketogenic diet. In contrast to Akita mice, the ketogenic diet did not
completely normalize blood glucose in db/db mice, but did reduce
blood glucose by about 50%. Nevertheless, within 8 weeks of
switching to the ketogenic diet, albuminurea was almost
completely corrected (Figure 1B).
Reversal of stress- and toxicity-related gene expression
induced with Type 1 and Type 2 diabetes in kidney
In view of the functional reversal of diabetic nephropathy by the
ketogenic diet, we examined if the functional reversal was
accompanied by reversal of molecular evidence of diabetes-induced
toxicity. To carry out this assessment we examined expression of
genes implicated in response to cellular stress, particularly oxidative
stress, using quantitative PCR arrays (SABiosciences). This analysis
led us to discover 9 genes whose expression in kidney is induced
both in Type 1 and in Type 2 diabetes (Figure 2; Table 2). In
general the induction of these genes was more robust in Akita than
in db/db mice. Of particular interest, the elevated expression of
every gene was completely reversed by the ketogenic diet in Akita
mice and largely or completely reversed in db/db mice, which is
remarkably consistent with effects on albuminuria. One gene,
Fmo1,was inhibitedinboth Type1 andType2 diabetes(Figure2J),
and this inhibition was completely reversed in both conditions by
the ketogenic diet. IL-18 (Figure 2K) exhibited yet a different
pattern, in that its expression wasnot influenced by diabetes but was
inhibited by the ketogenic diet, which could thereby produce some
protective effect directly.
Consistent with the generally more robust effect of Type 1 vs.
Type 2 diabetes on kidney gene expression, there were a number
of genes whose expression in kidney was influenced in Akita mice
but not db/db mice. Of particular interest were the inhibition of
nephrin, podocin, and Z0-1, expression of which is inhibited in the
streptozotocin model of Type 1 diabetes and whose inhibition is
plausibly contributory to impaired function in diabetic nephrop-
athy [25] (Figure 3A). As with the stress-induced genes, the effect
of diabetes on the expression of these genes was completely
reversed by the ketogenic diet, which would plausibly contribute to
the reversal of nephropathy. Conversely, the induction of three
genes, Nox1, Nox4, and Txnip, by diabetes plausibly contributes
to pathology by producing oxidative stress [4,23], and the
complete reversal of the elevation of these genes by the ketogenic
diet plausibly contributes to the reversal of neuropathy. In
contrast, the elevation of Hmox1, Hmox2, and Gpx2 by diabetes
probably reflects, rather than causes, oxidative stress, and the
reversal of the elevation of these genes probably reflects reversal of
the oxidative stress (as was probably the case in most of the genes
shown in Figure 2). Although the graphs in Figure 3A were those
for whose effects of diabetes were significant, the consistent pattern
for other stress-related genes to be elevated by diabetes and
reversed by the ketogenic diet was quite striking for both genes
associated with oxidative stress (Figure 3B) and genes associated
with other forms of cellular stress (Figure 3C).
Although fewer stress-related genes were induced in kidney
from db/db than Akita mice, at least one gene, Duox1, was
induced in db/db but not in Akita mice (Figure 4A). This gene is a
member of the NADPH oxidase gene family and thus, as with
Nox1 and Nox4 in kidneys from Akita mice, its induction with
diabetes plausibly contributes to the development of nephropathy,
and its reversal by the ketogenic diet plausibly contributes to the
Table 2. List of genes whose expression is described in the
manuscript.
Symbol GeneID Gene Name
Casp8 12370 Caspase 8
Cdkn1a 12575 Cyclin-dependent kinase inhibitor 1A (P21)
Duox1 99439 Dual oxidase 1
Ercc6 319955 Excision repair cross-complementing rodent repair
deficiency, complementation group 6
Fmo1 14261 Flavin containing monooxygenase 1
Gpx2 14776 Glutathione peroxidase 2
Gpx3 14778 Glutathione peroxidase 3
Gsr 14782 Glutathione reductase
Gstk1 76263 Glutathione S-transferase kappa 1
Hmox1 15368 Heme oxygenase (decycling) 1
Hmox2 15369 Heme oxygenase (decycling) 2
IL18 16173 Interleukin 18
Lta 16992 Lymphotoxin A (TNF-beta)
Mt2 17750 Metallothionein 2
Nephrin 54631 nephrosis 1 homolog (human), Nphs1
Nos2 18126 Nitric oxide synthase 2, inducible
Nox1 237038 NADPH oxidase 1
Nox4 50490 NADPH oxidase 4
Nqo1 18104 NAD(P)H dehydrogenase, quinone 1
Podocin 170484 nephrosis 2 homolog (human), Nphs2
Sod1 20655 Superoxide dismutase 1, soluble
Txnip 56338 Thioredoxin interacting protein
ZO-1 21872 Zonula occludens 1, tight junction protein 1 (tjp1)
doi:10.1371/journal.pone.0018604.t002
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unusual pattern, in that it is not influenced by diabetes but was
induced by the ketogenic diet in both wild-type and db/db mice
(Figure 4A), suggesting that the induction of Sod1 could mediate
part of the protective effect of the ketogenic diet. Consistent with
the observation that effects of diabetes in db/db mice were less
robust than in Akita mice, the heat-maps of stress-induced genes
exhibited less robust effects of gene expression, though some
induction of these genes, and reversal of the induction, was still
discernable (Figure 4B, 4C).
Partial reversal of histological evidence of pathology in
diabetes
As shown in Figure 5, in contrast to albumin/creatine ratios
that were completely reversed by the ketogenic diet, histological
pathology (e.g., glomerular sclerosis) was only partially (though
Figure 3. Nephropathy-related gene expression in the diabetic Akita mice is reversed by the ketogenic diet. (A) Kidney gene
expression changes associated with the Akita mutation and not in the db/db diabetics that are reversed by the ketogenic diet. The pattern of reversal
is particularly evident in the clusterograms form the entire (B) Oxidative Stress and Antioxidant Defense PCR Array and (C) Stress & Toxicity PCR array
from SABiosciences. The clusterograms (heat maps) represent relative expression levels for all samples and all genes included on the real-time PCR
arrays. Data for each gene in (A) was normalized to a panel of housekeeping transcripts and expressed as fold change compared to the WT-Chow
group (except for nephrin, podocin, and zo-1 – see Research Design and Methods). Data are means 6 SE (n=4–5 for all groups). *p,0.05 (ANOVA) vs.
WT-Chow group (or vs. diabetic-Chow groups as indicated by the horizontal brackets).
doi:10.1371/journal.pone.0018604.g003
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18604Figure 4. Kidney expression of duox1 and sod1 is affected by the ketogenic diet in db/db diabetic mice. (A) Ketogenic diet induces Sod1
expression and normalizes Duox1 expression in the db/db mice. The transcripts that show consistent patterns across db/db data sets are depicted in
the clusterograms from the (B) Oxidative Stress and Antioxidant Defense PCR Array and (C) Stress & Toxicity PCR array from SABiosciences. The
clusterograms (heat maps) represent relative expression levels for all samples and selected genes included on the real-time PCR arrays. Data for each
gene in (A) was normalized to a panel of housekeeping transcripts and expressed as fold change compared to the WT-Chow group. Data are means
6 SE (n=4 for all groups). *p,0.05 (ANOVA) vs. WT-Chow group (or vs. diabetic-Chow groups as indicated by the horizontal bracket).
doi:10.1371/journal.pone.0018604.g004
Figure 5. Improvement in glomerular histopathology in diabetic db/db mice fed the ketogenic diet. Morphometric study demonstrating
the mean values of glomerular deposition of PAS positive material(A) (% of total glomerular area) in db/db using light microscopy in fixed kidney
stained with periodic-acid-Schiff stain as described in Research Design and Methods. Images of representative glomerular histology from WT-Chow (B),
WT-Keto (C), db/db-Chow (D), db/db-Keto (E). *p,0.05 (ANOVA) vs. Control groups (or vs. db/db-Chow group - horizontal bracket).
doi:10.1371/journal.pone.0018604.g005
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Representative glomerular histology is presented in Figure 5
(panels B–E). These conclusions were corroborated by a blind
qualitative assessment of the mesangial matrix expansion rating
using a scale of 0–3. These data suggest that reversal of functional
and molecular markers of nephropathy occur more rapidly than
reversal of histological markers of nephropathy.
The ketone 3-OHB is cytoprotective
To further assess potential mechanisms mediating the protective
effects of the ketogenic diet, and since glucose toxicity in diabetes is
thought to be mediated by glucose-induced oxidative stress, we
assessed if the ketone 3-OHB would protect cells from oxidative
stress enhanced by either high or low glucose. As shown in
Figure 6, 3-OHB produced a dose-responsive cytoprotective effect
at both elevated and reduced glucose.
Discussion
In contrast to previous studies in which good glucose control
prevented, but did not reverse, nephropathy in a model of Type 1
diabetes [2], in the present studies the ketogenic diet reversed
nephropathy, as reflected by albumin/creatinine ratios, after it
had developed in models of both Type 1 and Type 2 diabetes. The
reversal of functional nephropathy was associated with robust
normalization of expression of genes induced by oxidative and
other forms of stress. In contrast to the complete reversal of
nephropathy as reflected by albuminuria and gene expression,
histological evidence of nephropathy was only partially reversed in
the model for Type 2 diabetes (kidneys from the Akita mice were
not available for histological analysis). This suggests, perhaps not
surprisingly, that functional and molecular aspects of nephropathy
reverse more quickly than morphological aspects of diabetic
nephropathy.
The present study also confirmed and greatly extended the
number of molecular markers for diabetic nephropathy, especially
for genes whose expression in kidney is induced in models of both
Type 1 and Type 2 diabetes. The gene most robustly induced in
both forms of diabetes was Cdkn1a, also known as p21 (Figure 2A).
Cdkn1a was induced over 20-fold in Akita mice though only about
4-fold in db/db mice, consistent with the generally more robust
effect of diabetes on gene expression in Akita mice compared to db/
db mice, though interestingly albuminuria was greater in db/db
mice than in Akita mice. Although induction of p21 has been
reported in a rat model of Type 1 diabetic nephropathy [26], the
functional significance of this observation is unclear. P21 is induced
by a number of cellular stressors and generally appearsto play a role
in ameliorating stresses, including DNA damage [27], so it seems
likely that in the present studies the induction of p21 and its reversal
by the ketogenic diet reflects pathological processes rather than
mediating the reparative effects of the ketogenic diet. Indeed, this
appears to be the case for the vast majority of the genes whose
expression was induced in both forms of diabetic nephropathy and
whose induction was reversed by the ketogenic diet. Possible
exceptions to this pattern are Nox1, Nox4, Txnip, and Duox1,
whose induction all plausibly contribute to the development of
oxidative stress [4,23], and thus whose inhibition by the ketogenic
diet all plausibly contribute to the restorative effects of the ketogenic
diet. Similarly, Casp-8 was inhibited by the ketogenic diet in
diabetic mice, and it has been reported that in db/db mice decreased
caspase-8 activity correlates with decreased progression of diabetic
nephropathy with moderate exercise [28], and podocyte apoptosis
appears to be a feature of advanced diabetic nephropathy [26].
More directly reflective of nephropathy are the inhibition of
nephrin, podocin, and ZO-1, all of which contribute to normal
kidney function and restoration of which by the ketogenic diet
plausibly reflects restoration of normal kidney function.
We also note that in contrast to the robust weight loss that the
ketogenic diet produces in diet-induced obesity [13], the ketogenic
diet increased, rather than decreased, body weight in db/db mice
(Table 1). Furthermore, weight gain occurred even though caloric
intake decreased. It has similarly been reported that the ketogenic
diet does not reduce body weight in leptin-deficient ob/ob mice
[29], which we have also observed (Mastaitis, unpublished). Thus
the weight gain observed in db/db mice, in contrast to the weight
loss in wild-type mice, is presumably due to the fact leptin
signaling is required for the reduction in body weight by the
ketogenic diet, and the weight gain despite reduced caloric intake
presumably reflects reduced metabolic rate. It will be of interest to
determine which cell types mediate this requirement for leptin in
weight loss by the ketogenic diet.
A key issue raised but not resolved in the present study is the
mechanism by which the ketogenic diet reverses nephropathy and
gene expression profiles associated with nephropathy. One
potential mechanism is that the reversal was simply due to
reduction in blood glucose. However, since previous studies
demonstrated that good glucose control prevented, but did not
reverse, diabetic nephropathy [2], and since diabetic complica-
tions are thought to be caused by increased cellular metabolism of
glucose [30], we hypothesize that at least part of the restorative
effect was mediated by reduction of glucose metabolism. This
hypothesis is supported by several lines of evidence. First, the
ketogenic diet appears to reduce the frequency of epileptic seizures
by reducing glucose metabolism [11,12]. Second, molecular
responses to the ketogenic diet indicates a re-routing of cellular
metabolism away from glucose utilization and toward the use of
alternative fuels [13,14]. Finally, we have shown that ketone 3-
OHB blocks molecular effects of glucose [9]. We therefore
hypothesize that the ketogenic diet reverses diabetic nephropathy
by raising blood levels of 3-OHB which subsequently reduce
glucose metabolism in at least some tissues including kidney. Since
Figure 6. The ketone 3-beta-hyroxybutyrate (3-OHB) is cyto-
protective in cells exposed to 100 uM hydrogen peroxide, at 0
or 15 mM glucose. p,0.001, ANOVA, significant effect of 3-OHB at
both glucose concentrations. * p,0.05 vs. 0 3-OHB. Viability
determined by a colorimetric (CCK-8; Dojin Laboratories, Kumamoto,
Japan).
doi:10.1371/journal.pone.0018604.g006
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of conditions [31], a phenomenon we have corroborated in the
present study (Figure 6), it seems highly likely that the ketogenic
diet will be protective in diabetic neuropathy and possibly
retinopathy as well.
Although the present studies represent a proof of principle that
pathologies produced by diabetes can be reversed by a simple
dietary manipulation, many issues remain to be resolved before
clinical application can be considered. First, the ketogenic diet is
probably too extreme for chronic use in adult patients, and
indeed may produce untoward iatrogenic effects. On the other
hand, based on hysteretic mechanisms observed with the lac
operon [7,8], it is plausible that only transient exposure to the
diet will effectively reverse the gene expression profile and thus in
effect ‘‘reset’’ the pathological process. If so it is plausible that
only a sustainable transient exposure to the diet may be needed to
produce persistent reversal of pathologies associated with
diabetes. Furthermore, if the mechanism by which the diet
produces its protective effects is in fact the elevation of blood 3-
bOHB, it is possible that a pharmacological intervention that
mimics these effects might be sufficient to reverse pathology.
Although we have not yet been successful in chronically elevating
plasma 3-bOHB by chronic mini-pump infusion, dietary
supplementation remains a possibility, including supplementation
with ketogenic derivatives [32]. We have also demonstrated that
chronic administration of the structurally similar molecular
butyrate (differing only by a single oxygen atom) mimics many
of the protective effects of dietary restriction through a
mechanism dependent on the transcription factor CBP [33], so
assessing the efficacy of this or related molecules in reversing
pathologies due to diabetes would also be of great interest.
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